Entera Bio Ltd. (ENTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

The company hosts events for trading card, anime, gaming and pop culture enthusiasts across the U.S. By Alex Weprin Senior Editor MARI, the holding company founded by Ari Emanuel and Mark Shapiro, is ...

Fans and cosplayers flooded an intellectual property (IP) festival that debuted in Hong Kong on Saturday, featuring pop culture exports such as the hit franchise Godzilla as well as local designs and ...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis - FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with ...

TEL AVIV, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced ...

New Chairman Joins Entera’s Board with Senior Global Leadership Experience from Pfizer, Wyeth and Other Leading Biopharma Companies as Entera Advances Multiple Oral Peptide Programs Toward Significant ...

Sometimes, the internet delivers a fact you may or may not feel ready for. For instance, recently, X users learned that Stuart Little is not, in fact, a mouse. A viral video previously taught ...

Con Edison has agreed to sharply scale back proposed rate hikes for electric and gas customers in New York City and Westchester County. Under a new three-year agreement, a previously proposed 11.4% ...

Con Edison has agreed to cut proposed rate hikes under a new three-year plan. Under the new proposal, New York City and Westchester County customers would see increases of 2.8% on the average electric ...

Sept 23 (Reuters) - President Donald Trump dismissed climate change as “the greatest con job” in the world during his address to the United Nations General Assembly on Tuesday, doubling down on his ...

FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment ...